RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/29273789http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/29273789http://www.w3.org/2000/01/rdf-schema#comment"Reduced clearance of lipoproteins by HDL scavenger receptor class B1 (SR-B1) plays an important role in occlusive coronary artery disease. However, it is not clear how much microvascular dysfunction contributes to ischemic cardiomyopathy. Our aim was to determine the distribution of vascular dysfunction in vivo in the coronary circulation of male mice after brief exposure to Paigen high fat diet, and whether this vasomotor dysfunction involved nitric oxide (NO) and or endothelium derived hyperpolarization factors (EDHF). We utilised mice with hypomorphic ApoE lipoprotein that lacked SR-B1 (SR-B1-/-/ApoER61h/h, n = 8) or were heterozygous for SR-B1 (SR-B1+/-/ApoER61h/h, n = 8) to investigate coronary dilator function with synchrotron microangiography. Partially occlusive stenoses were observed in vivo in SR-B1 deficient mice only. Increases in artery-arteriole calibre to acetylcholine and sodium nitroprusside stimulation were absent in SR-B1 deficient mice. Residual dilation to acetylcholine following L-NAME (50 mg/kg) and sodium meclofenamate (3 mg/kg) blockade was present in both mouse groups, except at occlusions, indicating that EDHF was not impaired. We show that SR-B1 deficiency caused impairment of NO-mediated dilation of conductance and microvessels. Our findings also suggest EDHF and prostanoids are important for global perfusion, but ultimately the loss of NO-mediated vasodilation contributes to atherothrombotic progression in ischemic cardiomyopathy."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.org/dc/terms/identifier"doi:10.1038/s41598-017-18485-6"xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Chen Y.C."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Nishida M."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Zhang Y."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Yamashita S."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Yoshimoto M."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Kelly D.J."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Shirai M."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Inagaki T."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Komuro I."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Pearson J.T."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Tsuchimochi H."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Nakaoka H."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Jin H.L."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Umetani K."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Schwenke D.O."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Edgley A.J."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Waddingham M.T."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/author"Sultani R."xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/name"Sci Rep"xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/pages"18108"xsd:string
http://purl.uniprot.org/citations/29273789http://purl.uniprot.org/core/title"Widespread Coronary Dysfunction in the Absence of HDL Receptor SR-B1 in an Ischemic Cardiomyopathy Mouse Model."xsd:string